Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arcutis Biotherapeutics Inc.

14.21
-0.1600-1.11%
Post-market: 14.210.00000.00%18:37 EDT
Volume:1.55M
Turnover:22.03M
Market Cap:1.69B
PE:-13.66
High:14.85
Open:14.75
Low:14.08
Close:14.37
Loading ...

Arcutis Biotherapeutics Promotes Vairavan to CFO as Topper Plans Retirement

Dow Jones
·
11 Apr

Arcutis Biotherapeutics Names New Chief Financial Officer

MT Newswires Live
·
11 Apr

Arcutis Biotherapeutics CFO David Topper to retire, Latha Vairavan to succeed

TIPRANKS
·
11 Apr

BRIEF-Arcutis Announces Chief Financial Officer Transition

Reuters
·
11 Apr

Arcutis Announces Chief Financial Officer Transition

THOMSON REUTERS
·
11 Apr

Arcutis Biotherapeutics Inc - CFO David Topper to Retire

THOMSON REUTERS
·
11 Apr

Press Release: Arcutis Announces Chief Financial Officer Transition

Dow Jones
·
11 Apr

Arcutis Biotherapeutics Price Target Maintained With a $20.00/Share by Needham

Dow Jones
·
09 Apr

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
05 Apr

Arcutis Biotherapeutics Price Target Maintained With a $20.00/Share by Needham

Dow Jones
·
03 Apr

Strategic Advantage and Market Confidence: Arcutis Biotherapeutics’ Extended Exclusivity and Buy Rating Amidst Competitive Risks

TIPRANKS
·
03 Apr

Why Arcutis Biotherapeutics Inc. (ARQT) Went Up On Wednesday?

Insider Monkey
·
03 Apr

Arcutis Biotherapeutics (ARQT) Receives a Buy from Mizuho Securities

TIPRANKS
·
03 Apr

BRIEF-Arcutis And Padagis Agree To Stay Patent Lawsuit

Reuters
·
03 Apr

BUZZ-Arcutis rises after halting patent dispute with Padagis

Reuters
·
03 Apr

Arcutis Agrees to Stay Patent Lawsuit Against Padagis

MT Newswires Live
·
03 Apr

Arcutis Biotherapeutics: Padagis to Report to Co Any FDA Correspondence About Anda for Their Generic Alternative to Zoryve Cream 0.3%

THOMSON REUTERS
·
03 Apr

Arcutis and Padagis Agree to Stay Patent Lawsuit

THOMSON REUTERS
·
03 Apr

How Much Upside is Left in Arcutis Biotherapeutics (ARQT)? Wall Street Analysts Think 25.85%

Zacks
·
28 Mar

Are Medical Stocks Lagging Cardinal Health (CAH) This Year?

Zacks
·
28 Mar